Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
about
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromesEULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndromeActivation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndromeNCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndromeB cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndromeSerum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.Distribution of Peripheral Lymphocyte Populations in Primary Sjögren's Syndrome Patients.Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndromeDecreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.Treating Sjögren's Syndrome: Insights for the ClinicianTemporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.Biologic treatments for systemic rheumatic diseasesThe BLyS family: toward a molecular understanding of B cell homeostasis.Cytokines in Sjögren's syndrome.Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activitySerum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection.Active immunological profile is associated with systemic Sjögren's syndrome.Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
P2860
Q33372523-2549ED3E-9808-4650-A1C3-AD32104D3B68Q33799767-FF09732A-2320-47D4-8141-9D8BB3ED3DE0Q34083843-3F24AACD-1360-4265-A22B-8D8CD2805326Q34117422-4363EBB3-ABB6-4CB3-AF85-76E7137EB98EQ34479625-18BCD2E4-CAC2-4515-928D-C2B8B34252C4Q34541173-9A8878A4-6EA7-4F73-A00F-A4CD8EDA3289Q34743817-E28ACDAC-5109-4C09-A545-3D4A58B2F760Q34896464-153D5DF1-C229-408B-B7A4-E8833A208747Q34896699-90B9286E-58B7-4CB7-AE8D-93872011E90DQ35638270-76E182DF-57E7-4F25-ACDA-0D8A1EE0C71FQ35673732-A0760E5B-BEDC-490D-A218-46FA5A349DBEQ35868945-8AB23A01-8333-4D88-8C63-C0F3798DEF9EQ35953373-68C8727A-939B-4D86-BA70-C62EAFEF705EQ36056942-1FB3A51B-1693-45B1-862F-B49E7EE7DAE9Q36214855-AB6848A6-D05A-42B8-96F3-4889A38EAFF2Q36219673-BFD12D0B-CC1E-44C6-87EB-016053886854Q37087438-CC612D10-5C6F-4AEE-921A-DAAA7CEBA2CEQ37335169-0B124689-5DF7-4475-ABF5-56861C34DD9BQ37387713-BD3D226F-27F3-40DA-A265-2DB69BB742D8Q37454013-028D7CB1-0561-4C7B-8981-AA7E6AA1782CQ37542648-6C81B843-61F6-4D7A-A322-337677E475DDQ37925863-0E92E3D9-94F8-4A7A-BACA-D4A21CB5978CQ43545216-C5E78311-9FFF-4839-81E7-253375546664Q48897306-F9CD5C3D-A3E0-4DB2-9AB7-4E185DEEF4EDQ50703280-501F7E6F-F460-48ED-984E-E68EF3403FF8Q51120450-5B7AFFD7-5128-4E62-8A41-AA00A1243DE9
P2860
Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Correlation of serum B lymphoc ...... in primary Sjogren's syndrome.
@ast
Correlation of serum B lymphoc ...... in primary Sjogren's syndrome.
@en
type
label
Correlation of serum B lymphoc ...... in primary Sjogren's syndrome.
@ast
Correlation of serum B lymphoc ...... in primary Sjogren's syndrome.
@en
prefLabel
Correlation of serum B lymphoc ...... in primary Sjogren's syndrome.
@ast
Correlation of serum B lymphoc ...... in primary Sjogren's syndrome.
@en
P2093
P2860
P356
P1476
Correlation of serum B lymphoc ...... in primary Sjogren's syndrome.
@en
P2093
Cohen-Solal J
Gottenberg JE
Kimberly RP
Mariette X
P2860
P304
P356
10.1136/ARD.2004.030643
P407
P577
2005-01-07T00:00:00Z